Parameter
| Biomarker | PLA2R1 | Full name | Phospholipase A2 receptor 1 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Risk prediction, immune regulation | ||
| Disease | Esophageal Carcinoma | Disease Subtypes | / | ||
| Organ | Esophagus | Test Sample / Technology Platform | Tissue/plasma (MR Analysis, qPCR) | ||
| Pathobiological Mechanisms | It is involved in the regulation of phospholipid metabolism and immune response, and its high expression increases the risk of ESCC and affects disease progression by regulating the inflammatory response of tumor microenvironment | ||||
| Clinical Availability Status | Clinical research stage: Mendelian randomization analysis confirmed the causal relationship between the tumor and ESCC, and the immune regulation mechanism needs further study | ||||
| Notes and Dynamics | It is a potential risk marker related to ESCC metabolism, which provides a new direction for multi-target combined therapy | ||||